Bioworld Financial Watch articles from May 2005

Bioworld Financial Watch archives from May 2005

Adventrx's biomodulator adds weaponry to cancer arsenal.
May 2, 2005... Say "chemotherapy" and most people cringe, conjuring a mental picture of a sunken-eyed, hairless cancer patient who vomits constantly, breaks out in a rash and stays indoors to avoid the bright light of day. Though somewhat dramatic, the...

10 biggest U.S. gainers for the week.
May 2, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Oxis Int'l 41.38 Tapestry Pharma 34.04 LifeCell 31.15 Interleukin 22.58 La Jolla Pharma 20.45 Corcept 19.40 Generex Biotech 17.11...

10 biggest U.S. losers for the week.
May 2, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Martek Bio -35.79 Biotime -27.78 Immunicon -23.83 Connetics Corp. -22.39 Questcor Pharma -19.40 Avant Immuno -18.67 Genaissance...

Collaborations between biotech and pharmaceutical companies: new agreements, Feb. 24-April 28, 2005 (#).
May 2, 2005... Collaborations Between Biotech And Pharmaceutical Companies: New Agreements, Feb. 24-April 28, 2005 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Affymetrix ...

Manufacturing, marketing and distribution agreements between biotech and pharmaceutical companies: Feb. 24-April 27, 2005 (#).
May 2, 2005... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Feb. 24-April 27, 2005 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Advancis ...

Biotech--big pharma collaborations: modified and terminated agreements, Feb. 24-April 27, 2005 (#).
May 2, 2005... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Feb. 24-April 27, 2005 (#) I. MODIFIED AGREEMENTS Biotech Co.* Pharma Co. Change from original (Country; (Country) ...

BioWorld stock report for public biotechnology companies.
May 2, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 4/22 4/29 ...

Tysabri slump creates buying edge for long-term investors.
May 9, 2005... When Amylin Pharmaceuticals Inc. won approval of its second diabetes drug in as many months, Byetta (exenatide), the company's stock--rather than skyrocketing, as likely would have happened in the old days--fell 6 percent. Some investors...

Money raised by biotech in 2005: January-April.
May 9, 2005... Money Raised By Biotech In 2005: January-April Total Type of Jan. Feb. March April ($M) financing Public offerings 585.7 799.4 303.9...

10 biggest U.S. gainers for the week.
May 9, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Renovis 111.61 ViroPharma 48.21 Alteon 45.61 Corixa 40.13 CoTherix 37.90 Seattle Genetics 37.75 Miravant ...

10 biggest U.S. losers for the week.
May 9, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ortec Int'l -34.67 Cardiovascular Bio -27.50 Oxis Int'l -24.39 Biotime -24.36 Praecis -21.88 Gen-Probe -16.68 Corcept...

Public financing of biotechnology: April 2005.
May 9, 2005... Public Financing Of Biotechnology: April 2005 I. COMMENCED TRADING IN APRIL Company Date Date Shares/ Price Shares (Symbol) (#) Filed Comm. Units (M) Out ...

Other financings of public biotechnology companies: April 2005.
May 9, 2005... Other Financings Of Public Biotechnology Companies: April 2005 TOTAL: $309.18M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: April 2005.
May 9, 2005... Venture Capital And Corporate Investments In Biotechnology Companies: April 2005 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $182.14M Company Location Date Amt. (M) Actimis San Diego ...

BioWorld stock report for public biotechnology companies.
May 9, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close Vol 4/29 5/6 WK ...

Renovis: an alternative, finally, to TPA for patients with stroke?(After 36 Other Trials Failed)
May 16, 2005... Ischemic stroke--it's the category (the other is hemorrhagic) into which about 85 percent of all strokes fall. Blood suddenly stops going to a specific area of the brain because of a blood clot, thus "impairing neurologic function," as the...

10 biggest U.S. gainers for the week.
May 16, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) ViroPharma 40.56 Oxis Int'l 35.48 Genta 27.93 GTC Biothera 25.53 Vertex Pharma 20.09 Albany Molecular 19.82 Hana Bio ...

10 biggest U.S. losers for the week.
May 16, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) NeoRx Corp. -28.79 Aphton -25.74 Regeneration -23.43 Santarus -17.62 Generex Biotech -17.58 Trinity Bio -17.37...

Clinical trials update: April 2005.
May 16, 2005... Clinical Trials Update: April 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Arakis Ltd. * AD 452 Small-molecule disease- (UK) modifying...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: April 2005.
May 16, 2005... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: April 2005 Company * Product Description (Country; Symbol) AUTOIMMUNE Biogen Idec BG-12 Oral fumarate...

FDA submissions, approvals and other actions: April 2005.
May 16, 2005... FDA Submissions, Approvals And Other Actions: April 2005 Company * Product Description (Country; Symbol) CANCER Ariad AP23573 Small molecule designed Pharmaceuticals ...

BioWorld stock report for public biotechnology companies.
May 16, 2005... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close Vol 5/6 5/13 ...

Post-ASCO, opinions mixed on kidney cancer drug race.
May 23, 2005... Late last year, when Onyx Pharmaceuticals Inc. and partner Bayer Pharmaceuticals Corp. disclosed their plan to hold off seeking approval of their kidney cancer drug sorafenib (previously BAY 43-9006) until they had Phase III data in hand, Wall...

10 biggest U.S. gainers for the week.
May 23, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Aeolus 41.67 Cel-Sci 39.22 Exact Sciences 34.96 Aastrom Biosci 34.47 SternCells 32.01 Hana Bio 22.58 Nanogen ...

10 biggest U.S. losers for the week.
May 23, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Xcyte Therapies -21.18 Vernalis -16.27 Onyx Pharma -16.23 Kosan -15.44 Biopure -15.15 Novavax -14.71 Biotime ...

Collaborations between biotechnology companies and government/nonprofit institutions: March 18-May 19, 2005.
May 23, 2005... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: March 18-May 19, 2005 Company * University/ Type Of Product Area (Country; Symbol) Nonprofit (@) Agreement Aegis ...

BioWorld stock report for public biotechnology companies.
May 23, 2005... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close Vol 5/13 5/20 ...

Former Merck CEO: value highly 'big-bet' scientists.(Allicense 2005)
May 30, 2005... SAN FRANCISCO -- Industry leader and self-made man Roy Vagelos, former chairman and CEO of Merck & Co. Inc., offered words of wisdom about keeping talent in the coming half-century, which he told attendees of Allicense 2005 will be vastly more...

10 biggest U.S. gainers for the week.
May 30, 2005... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Indevus 35.69 Tapestry Pharma 24.49 CoTherix 23.56 Isis Pharma 22.34 Hana Bio 21.05 Targeted Genetics 20.27 ViroPharma ...

10 biggest U.S. losers for the week.
May 30, 2005... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Ortec Int'l -43.64 Eyetech -43.18 Deltagen -21.43 Aeolus -16.47 Large Scale -16.33 Cellegy Pharma -15.71 Cel-Sci -15.49...

Grants, contracts and awards to biotech companies: March 25-May 25, 2005.
May 30, 2005... Grants, Contracts And Awards To Biotech Companies: March 25-May 25, 2005 Company * Funding Amount (Country; Symbol) Institution (M) Achillion National Institute ND Pharmaceuticals...

BioWorld stock report for public biotechnology companies.
May 30, 2005... BioWorld Stock Report For Public Biotechnology Companies % Change Company Symbol Close Close WK YTD Vol 5/20 5/27 ...